OCULAR HYPERTENSION
Clinical trials for OCULAR HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new OCULAR HYPERTENSION trials appear
Sign up with your email to follow new studies for OCULAR HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glaucoma implant could replace daily eye drops
Disease control Not yet recruitingThis early study tests a small ring placed in the eye that slowly releases the drug bimatoprost to lower eye pressure in people with glaucoma or ocular hypertension. The ring is implanted during a quick surgery and may work for up to 3 years. The trial includes 24 adults and comp…
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE1 • Sponsor: SpyGlass Pharma, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Could a new eye drop beat an old favorite for glaucoma?
Disease control Not yet recruitingThis Phase 3 trial tests a new eye drop, DNN.31.19.026, against a standard treatment (Cosopt) for people with high eye pressure or open-angle glaucoma. About 336 adults will use the drops twice daily for 56 days. The main goal is to see if the new drop lowers eye pressure better …
Matched conditions: OCULAR HYPERTENSION
Phase: PHASE3 • Sponsor: Ache Laboratorios Farmaceuticos S.A. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New eye tests aim to catch glaucoma earlier
Diagnosis Not yet recruitingThis study looks at 60 adults with high eye pressure or early open-angle glaucoma to see if combining advanced eye scans and vision tests can detect damage sooner. Participants will have standard eye exams plus special imaging of the optic nerve. The goal is to improve how doctor…
Matched conditions: OCULAR HYPERTENSION
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Diagnosis
Last updated Jun 27, 2026 07:54 UTC